Johnson & Johnson's Wang Jinhe Highlights AI-Driven Medical Innovation Strategy at 2019 Global AI Health Summit

Shanghai, September 3, 2019 /PRNewswire/ -- Recently,2019 World Artificial Intelligence Conference Held in ShanghaiAs one of the thematic forums of the World Artificial Intelligence Conference, the 2019 Global AI Health Summit, themed “Smart Health, Foreseeing the Future,” brought together industry elites to focus on key issues in technological healthcare. Wang Jinhe, General Manager of the Cardiovascular and Specialty Solutions segment at Johnson & Johnson Medical, was invited to attend the summit and introduce Johnson & Johnson Medical’s strategic layout for leveraging artificial intelligence to accelerate medical innovation. At the roundtable forum on “New Perspectives on Policy Development for the AI Healthcare Industry,” Wang Jinhe engaged in in-depth dialogue and exchange with renowned experts and scholars from the global AI health sector, as well as leaders from smart healthcare enterprises, on how artificial intelligence drives the development of the healthcare industry.

Currently, with the rapid advancement of technology and the swift development of the digital era, artificial intelligence (AI) has become one of the key drivers transforming the health industry. The integration of AI with holistic health—“AI + Big Health”—to accelerate innovation is also garnering significant attention. In light of the broad market prospects brought about by the rapid development of AI and the growing public demand for healthcare, Wang Jinhe outlined the vision and initiatives of Johnson & Johnson MedTech, a global leader in healthcare. Guided by its Credo, the company continues to invest in innovation, collaborate with industry partners, and support the advancement of the AI-driven healthcare sector.

Wang Jinhe stated that innovation is the driving force behind medical development. Artificial intelligence encompasses a variety of advanced technological elements, including 5G technology, the internet, big data, cloud computing, and even the Internet of Things (IoT). To promote the deep integration of industry, academia, and research, and to facilitate AI-enabled growth in the healthcare industry, it is essential to build a healthy, open, and diverse innovation ecosystem. The more open and diverse this ecosystem is, the more vibrant its development will be. It will make positive contributions to effectively linking the entire industry chain, pooling expertise and advantages from all parties, and exploring innovative healthcare solutions, ultimately benefiting the well-being of more patients. “An open, diverse, and vibrant healthcare innovation ecosystem requires collaboration among regulatory bodies, industry players, investors, academic institutions, and other partners. Johnson & Johnson Medical is committed to working with industry partners to make relentless efforts in this regard, supporting and promoting the long-term development of an innovative economy and society.””

Wang Jinhe also put forward suggestions on promoting the standardization and structuring of big data to further reduce barriers to collaboration across the industrial chain. He stated that advancing the standardized and structured development of big data, while ensuring data security and patient privacy, can better facilitate collaboration and integration among all parties in the industrial chain. This includes leveraging de-identified big data to accelerate R&D innovation and provide feedback on clinical effectiveness and safety, thereby serving patients more effectively. “Johnson & Johnson Medical welcomes the proactive efforts made by regulatory authorities at all levels to create a favorable business environment. The innovative solutions from Johnson & Johnson Medical have received strong support from multiple favorable policies issued by regulators during the accelerated deployment of products and technologies and in the process of serving patients. We are deeply encouraged by this support and look forward to further policy backing in areas such as hospital admission and comprehensive management throughout the medical insurance process. We believe that, with the joint efforts of all stakeholders in the industry, the future of AI-enabled smart health in China will surely flourish.”。“Wang Jinhe emphasized, ‘Johnson & Johnson MedTech will continue to uphold our Credo and mission, working closely with the government and all sectors of society to build a vibrant, innovative healthcare ecosystem, and forging ahead to create a Healthy China and a healthier future!’”

Following the conference, Wang Jinhe accepted media interviews and engaged with the audience on-site. He introduced Johnson & Johnson MedTech’s business development in China, stating that with advancements in science and technology and emerging innovations such as artificial intelligence (AI), Johnson & Johnson MedTech is actively investing in strategic layout and innovative development in the AI field. This includes research into the impact of wearable devices on the early detection of atrial fibrillation and the development of smarter robotic-assisted surgical systems. He cited as an example how, under the favorable policies of the “Nine National Measures” green channel, Johnson & Johnson MedTech has introduced cutting-edge cardiac surgical treatments in the Boao Lecheng International Medical Tourism Pilot Zone in Hainan, synchronizing with international standards. This enables patients to benefit earlier from the safety and convenience offered by advanced medical technologies. Additionally, the “Johnson & Johnson Advanced Technologies Boao Education Center” was established to support physicians in accelerating their mastery of internationally advanced medical technologies urgently needed in clinical practice.

“2019 Global AI Health Summit” was organized by the Medical Management Service Guidance Center of the National Health Commission, the China Academy of Information and Communications Technology (CAICT), the Shanghai Municipal Commission of Economy and Informatization, the Xuhui District People's Government, and the Internet Healthcare Industry Alliance, with co-organization by the East China Branch of CAICT. The summit aimed to build a diversified, open, and innovative global platform for shared exchange, bringing together experts, scholars, and industry leaders in the field of AI health to conduct in-depth discussions on topics such as development trends, industry regulation, and innovative technologies in the AI health sector.